How AI and terminals describe SANGAMO THERAPEUTICS, INC

Your SEC industry code says "Biological Products, (No Diagnostic Substances)," while market data lists you under "Biotechnology." When classifications disagree, AI assistants and terminals pick one, and it is often the wrong one.

EDGAR lists SGMO as formerly "SANGAMO BIOSCIENCES INC" (through 2017-01-06). After a name change or reverse merger, AI engines and terminals routinely keep returning the old identity for the ticker. Investors searching SANGAMO THERAPEUTICS, INC may be shown the prior company, its old business, and its old numbers.

You are producing current primary disclosures. The open question is whether AI sources and terminals are actually reading them, which the full audit verifies.

OTC and Expert Market tickers are frequently thin or misrepresented in the data AI models were trained on, and in terminal records. This is exactly where a correction pass has the most effect.

AI assistants lean heavily on third-party coverage. With little recent news, they fall back to whatever description they already hold.

Get the full 24-hour AI Visibility audit

This page reads your public SEC record. The full Pulse IR audit adds what it cannot see: how ChatGPT, Perplexity, and Google AI actually answer "what is SGMO", how the major terminals (FactSet, S&P, Refinitiv, Bloomberg, TradingView) list you, whether you have a verified knowledge-graph entity, and the exact corrections to file. Delivered in 24 hours, free, no obligation. Enter your work email and we will send it.

For company management and investor relations. Pulse IR is the investor-relations firm behind PubCo Insight.